News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
CAPEK JOHN M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| CAPEK JOHN M (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 6,247 shares
@ $99.77, valued at
$623.3k
|
|
| 02/22/2023 |
4
| CAPEK JOHN M (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 15,855 shares
@ $0
Granted 62,527 options to buy
@ $106.24, valued at
$6.6M
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2020 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 52,300 shares
@ $111.86, valued at
$5.9M
Exercised 52,300 options to buy
@ $27.0336, valued at
$1.4M
|
|
| 04/23/2020 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 31,399 shares
@ $95.6314, valued at
$3M
Sold 18,701 shares
@ $96.2834, valued at
$1.8M
Exercised 50,100 options to buy
@ $22.3919, valued at
$1.1M
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 46,900 shares
@ $85, valued at
$4M
Exercised 46,900 options to buy
@ $26.1879, valued at
$1.2M
|
|
| 03/04/2019 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 9,132 shares
@ $77.23, valued at
$705.3k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 64,900 shares
@ $65, valued at
$4.2M
Exercised 64,900 options to buy
@ $26.015, valued at
$1.7M
|
|
| 03/02/2018 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 7,958 shares
@ $60.55, valued at
$481.9k
|
|
| 02/21/2018 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 28,276 shares
@ $0
Granted 155,495 options to buy
@ $59.94, valued at
$9.3M
|
|
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 9,980 shares
@ $39.52, valued at
$394.4k
|
|
| 02/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2015 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 12,312 shares
@ $47.61, valued at
$586.2k
|
|
| 02/24/2015 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 23,457 shares
@ $0
Granted 165,292 options to buy
@ $47, valued at
$7.8M
|
|
| 02/06/2015 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 3,900 shares
@ $45.82, valued at
$178.7k
Sold 800 shares
@ $45.825, valued at
$36.7k
Sold 100 shares
@ $45.8275, valued at
$4.6k
Sold 1,935 shares
@ $45.83, valued at
$88.7k
Sold 200 shares
@ $45.835, valued at
$9.2k
Sold 100 shares
@ $45.8375, valued at
$4.6k
Sold 300 shares
@ $45.845, valued at
$13.8k
Sold 2,200 shares
@ $45.85, valued at
$100.9k
Sold 400 shares
@ $45.86, valued at
$18.3k
|
|
| 02/06/2015 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 800 shares
@ $45.715, valued at
$36.6k
Sold 100 shares
@ $45.7175, valued at
$4.6k
Sold 2,300 shares
@ $45.72, valued at
$105.2k
Sold 1,300 shares
@ $45.725, valued at
$59.4k
Sold 100 shares
@ $45.7275, valued at
$4.6k
Sold 5,000 shares
@ $45.73, valued at
$228.7k
Sold 700 shares
@ $45.735, valued at
$32k
Sold 2,900 shares
@ $45.74, valued at
$132.6k
Sold 300 shares
@ $45.745, valued at
$13.7k
Sold 900 shares
@ $45.75, valued at
$41.2k
Sold 400 shares
@ $45.755, valued at
$18.3k
|
|
| 02/06/2015 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 100 shares
@ $45.57, valued at
$4.6k
Sold 100 shares
@ $45.5775, valued at
$4.6k
Sold 1,400 shares
@ $45.58, valued at
$63.8k
Sold 1,600 shares
@ $45.59, valued at
$72.9k
Sold 200 shares
@ $45.595, valued at
$9.1k
Sold 2,300 shares
@ $45.6, valued at
$104.9k
Sold 400 shares
@ $45.605, valued at
$18.2k
Sold 1,300 shares
@ $45.61, valued at
$59.3k
Sold 805 shares
@ $45.62, valued at
$36.7k
Sold 300 shares
@ $45.625, valued at
$13.7k
Sold 700 shares
@ $45.63, valued at
$31.9k
|
|
| 03/04/2014 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 13,263 shares
@ $39.79, valued at
$527.7k
|
|
| 02/25/2014 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 23,109 shares
@ $0
Granted 141,478 options to buy
@ $39.12, valued at
$5.5M
|
|
| 03/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/20/2013 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 28,800 shares
@ $0
Paid exercise price by delivering 12,147 shares
@ $35.08, valued at
$426.1k
Granted 149,600 options to buy
@ $34.94, valued at
$5.2M
|
|
| 03/07/2012 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 3,000 shares
@ $57.31, valued at
$171.9k
Sold 400 shares
@ $57.315, valued at
$22.9k
Sold 6,055 shares
@ $57.32, valued at
$347.1k
Sold 200 shares
@ $57.325, valued at
$11.5k
Sold 6,900 shares
@ $57.33, valued at
$395.6k
Sold 1,300 shares
@ $57.335, valued at
$74.5k
Sold 4,200 shares
@ $57.34, valued at
$240.8k
Sold 500 shares
@ $57.345, valued at
$28.7k
Sold 6,800 shares
@ $57.35, valued at
$390k
Sold 1,600 shares
@ $57.355, valued at
$91.8k
Sold 100 shares
@ $57.359, valued at
$5.7k
|
|
| 03/02/2012 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 14,884 shares
@ $57.04, valued at
$849k
|
|
| 02/22/2012 |
4
| CAPEK JOHN M (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 28,900 shares
@ $0
Granted 52,300 options to buy
@ $56.26, valued at
$2.9M
|
|
|
|
|